Related coverage linked through entity extraction aliases.
Jul 29, 2026
India's drug regulator has mandated stronger safety warnings for doxycycline and carbimazole after a national review of adverse reaction reports. Doxycycline packages will now list potential mental health side effects such as anxiety and dizziness, while carbimazole will warn of a rare blood disorder.
Jul 22, 2026
The FDA has approved Agios Pharmaceuticals' mitapivat (AQVESME) as the first oral treatment for anemia in thalassemia, reducing transfusion needs by 40-50%. Meanwhile, a clinical trial found a three-times-weekly dosing of vadadustat (Vafseo) is safe for kidney dialysis patients, potentially improving convenience.
Feb 18, 2026
Artificial intelligence is transforming pharmaceutical industry employment by creating hybrid roles and in-house AI teams rather than causing widespread job losses, with drug discovery emerging as the primary area for AI talent demand.
